- Dose Escalation Part: desmoid tumors, anaplastic thyroid cancer (ATC), endometrial cancer, melanoma, colorectal cancer (CRC), hepatocellular carcinoma (HCC), pancreatic cancer, prostate cancer, and ovarian cancer. Enrollment of additional tumor types will be discussed with the Sponsor and agreed on a case by case basis.